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Abstract: 
A considerable number of international research groups as well as commercial entities 
work on the development of new bone grafting materials, carriers, growth factors and 
specifically tissue engineered constructs for bone regeneration. They are strongly 
interested in evaluating their concepts in highly reproducible large segmental defects 
in preclinical and large animal models. To allow comparison between different studies 
and their outcomes, it is essential that animal models, fixation devices, surgical 
procedures and methods of taking measurements are well standardized to produce 
reliable data pools and act as a base for further directions to orthopaedic and tissue 
engineering developments, specifically translation into the clinic. In this leading 
opinion paper, we aim to review and critically discuss the different large animal bone 
defect models reported in the literature. We conclude that most publications provide 
only rudimentary information on how to establish relevant preclinical segmental bone 
defects in large animals.  Hence, we express our opinion on methodologies to 
establish preclinical critically-sized, segmental bone defect models used in past 
research with reference to surgical techniques, fixation methods and post-operative 
management focusing on tibial fracture and segmental defect models.
Abstract
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1. Clinical Background
In general, bone possesses a good healing capacity and the vast majority of 
bone defects, when stimulated by well balanced biological and micro-environmental 
conditions, heal spontaneously. Refinements in surgical techniques, implant design 
and peri-operative management have significantly improved the treatment of complex 
fractures and other skeletal defects caused by high energy trauma, disease, 
developmental deformity, revision surgery, and tumour resection [1-6]. However, an 
unfavourable wound environment, sub-optimal surgical technique or biomechanical 
instability can lead to formation of large defects with limited intrinsic regeneration 
potential [7]. Such defects pose a major surgical, socio-economical and research 
challenge and can highly influence the patient’s quality of life due to limb length 
discrepancy and prolonged, postoperative treatment courses [8, 9].
Even though cancellous bone fractures of the proximal humerus, distal radius 
or the tibia plateau often lead to impaction of bone and consequently a defect after 
reduction [4], the tibia shaft represents the most common anatomic site for segmental 
bone defects. This is because it is devoid of muscle coverage on its anteromedial 
surface [8]. The poor soft tissue coverage both increases the risk of bone loss and 
complicates treatment [8]. Historically, limb amputation was the principal treatment 
option when facing segmental, non-healing defect sites [10]. 
Over the years, bone grafts have advanced as the “gold standard” treatment to 
augment or accelerate bone regeneration [1, 2, 11-17]. However, significant 
drawbacks are associated with this approach. Additional anaesthetic time and 
personnel are needed for graft harvesting [13, 15, 18]. In many cases, insufficient 
grafts are obtained and the access to donor sites is limited [13, 14, 19, 20]. Donor site 
pain or haemorrhage can occur and the donor bone is predispositioned for failure [4, 
*Manuscript
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2
13, 14, 21]. Moreover, the risk of infection is significantly increased. Graft failures 
usually result from incomplete transplant integration, particularly in large defect sites
[15]. In addition, graft devitalisation and subsequent resorption processes can lead to 
decreased mechanical stability [22]. Vascularised autografts are technically 
demanding and allografts and xenografts carry the risk of immune-mediated rejection, 
graft sequestration and transmission of infectious disease [9, 23-29]. The dense nature 
of cortical bone allografts impedes revascularization and cellular invasion from the 
host following implantation [19]. This limited ability to revascularize and remodel is 
believed to be responsible for a failure rate of 25% and a 30-60% complication rate 
associated with allografts [19, 30]. In addition, the maintenance of bone banks is 
rather costly. A technique introduced to avoid graft integration-related difficulties is 
commonly referred to as the “Ilizarov technique” which involves osteotomy and 
distraction to stimulate bone formation. It is used as a treatment modality for large 
bone defects, infected non-unions, and limb length discrepancy [31]. However, the 
Ilizarov technique is a long-lasting procedure, highly inconvenient for the patient [32, 
33] with recurrent pin track infections as a frequent complication [25, 34].
In order to avoid the limitations associated with the current standard treatment 
modalities for segmental bone deficiencies, there has been a continuous interest in the 
use of naturally derived and synthetic bone graft substitutes during the past decades. 
More recently, the concept of tissue engineering has emerged as an important 
approach to bone regeneration research. Tissue engineering unites aspects of cellular 
biology, biomechanical engineering, biomaterial sciences and trauma and orthopaedic 
surgery. Its general principle involves the association of cells with a natural or 
synthetic supporting scaffold to produce a three-dimensional, implantable construct. 
To biomechanically simulate human in vivo conditions as closely as possible, and to 
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3
assess the effects of implanted bone grafts and tissue engineered constructs on 
segmental long bone defect regeneration, a number of large animal models have been 
developed. However, reviewing the current literature most of the preclinical models 
reported in the literature are not well described, defined and standardized. This year,
the Journal of Bone and Joint Surgery published a number of review papers on 
preclinical models in fracture healing and on non-unions [49]. However, these articles 
provide only rudimentary information on how to establish relevant preclinical 
segmental bone defects in a large animal model.  Hence, the aim of this leading 
opinion article is to provide both detailed information on the advantages and 
disadvantages of the different animal models and to comprehensively share the 
expertise and knowledge of three research groups that successfully established a 
preclinical animal model for critically sized segmental bone defects.
2. Definition of a Critical-Size Bone Defect
An experimental osseous injury inflicted to study bone repair mechanisms 
should be of dimensions to preclude spontaneous healing [35]. Therefore, the non-
regenerative threshold of bone was determined in research animal models inducing 
so-called critical-sized defects. Critical sized defects are defined as “the smallest size 
intraosseous wound in a particular bone and species of animal that will not heal 
spontaneously during the lifetime of the animal” [30, 36, 37] or as a defect which 
shows less than 10 percent bony regeneration during the lifetime of the animal [37]. 
Although the minimum size that renders a defect ‘‘critical’’ is not well 
understood, it has been defined as a segmental bone deficiency of a length exceeding 
2-2.5 times the diameter of the affected bone [25, 34]. Results of various animal 
studies suggest that critical sized defects in sheep, however, could be approximately 
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4
three times the diameter of the corresponding diaphysis [34]. Nevertheless, a critical 
defect in long bone cannot simply be defined by its size but may also be dependent on 
the species phylogenetic scale, anatomic defect location, associated soft tissue and 
biomechanical conditions in the affected limb as well as age, metabolic and systemic 
conditions, and related morbidities affecting defect healing [25, 36]. 
3. Large animal models in bone defect research
Animal models in bone repair research include representations of normal 
fracture-healing, segmental bone defects, and fracture non-unions in which regular 
healing processes are compromised without presence of a critical-sized defect site 
[38]. In critical-sized segmental defect models bridging of the respective defect does 
not occur despite a sufficient biological microenvironment due to the removal of 
critical amounts of bone substance. In contrast, in a true non-union deficient 
signalling mechanisms, biomechanical stimuli or cellular responses may prevent 
defect healing rather than the defect size.
When selecting a specific animal species as a model system, a number of factors 
need to be considered. In comparison to humans, the chosen animal model should 
clearly demonstrate both significant physiological and pathophysiological analogies in 
respect to the scientific question under investigation prior to animal selection. 
Moreover, it must be manageable to operate and observe a multiplicity of study 
objects post surgery over a relatively short period of time [39-41]. Further selection 
criteria include costs for acquisition and care, animal availability, acceptability to 
society, tolerance to captivity and ease of housing [42].
Several publications over the last decades have described dogs as a suitable 
model for research related to human orthopaedic conditions [43]. It was found that in 
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5
regard to bone weight, density and bone material constituents such as hydroxyproline, 
extractable proteins, IGF-1, organic, inorganic and water fraction, dogs were the 
closest to humans although clear differences in bone microstructure and remodelling 
have been described [44, 45]. While the secondary structure of human bone is 
predominantly organized in osteones, osteonal bone structure in dogs is limited to the 
core of cortical bone, whereas in areas adjoining the periosteum and endosteum 
mainly laminar bone is found. This is characteristic for large, fast-growing animals 
[46]. It has been reported that higher rates of trabecular and cortical bone turnover can 
be generally observed in dogs compared to humans [47] and differences in loads 
acting on the bone as a result of the dog’s quadrupedal gait must be taken into 
consideration as well. A review article by Neyt states that between 1991 and 1995 
11% of musculoskeletal research was undertaken in dogs. This is confirmed by 
Martini et al. who find that between 1970 and 2001, 9% of orthopaedic and trauma 
related research used dogs as animal models for orthopaedic and trauma-related 
research [43, 48]. Recently, the use of dogs as experimental models has significantly 
decreased mainly due to ethical issues, although between 1998 and 2008 
approximately 9% of articles published in leading orthopaedic and musculoskeletal 
journals described dogs as animal models for fracture healing research [49]. 
Mature sheep and goats possess a bodyweight comparable to adult humans and 
long bone dimensions enabling the use of human implants [50]. The mechanical 
loading environment occurring in sheep is well understood [51, 52]. The loading of 
the hind limb bones, forces and moments, is roughly half of that determined for 
humans during walking (Fig. 1). Since no major differences in mineral composition 
[53] are evident and both metabolic and bone remodelling rates are akin to humans 
[54], sheep are considered a valuable model for human bone turnover and remodelling 
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6
activity [55]. Bone histology however reveals some differences in bone structure 
between sheep and humans. In sheep, bone consists principally of primary bone 
structure [56] in comparison with the largely secondary, haversian bone composition 
of humans [57]; furthermore the secondary, osteonal remodelling in sheep does not 
take place until an average age of 7-9 years (Fig. 2)[50]. Although a significantly 
higher trabecular bone density and greater bone strength was described for mature 
sheep when compared to humans, the trabecular bone in immature sheep is weaker, 
has a lower stiffness and density, a higher flexibility due to higher collagen content 
[58], and shows comparable bone healing potential and tibial blood supply [59].
In a variety of study designs, pigs are considered the animal of choice and were -
despite their denser trabecular network [60] - described as a highly representative 
model of human bone regeneration processes in respect to anatomical and 
morphological features, healing capacity and remodelling, bone mineral density and 
concentration [44, 61]. However, pigs are often neglected in favour of sheep and goats 
given that the handling of pigs has been described as rather intricate [50]. 
Furthermore, the length of the tibiae and femora in the pig is relatively small, which 
causes the need for special implants, as one cannot use implants designed human use.
3.1. Tibial fracture models 
Animal fracture models have been widely investigated to identify and further 
characterize physiological and pathophysiological processes of fracture healing of 
long bones. One of the most important elements in the study of fracture healing or 
fixation is the establishment of standardized methods to create reproducible fractures. 
Although a substantial number of articles on fracture models in animals and treatment 
options have been described over the last decades, only few publications describe the 
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7
actual infliction of a fracture by trauma rather than the creation of a bony defect < 3 
mm size by osteotomy, which is generally accepted as an alternative since it is less 
problematic to standardize. In 1988, Macdonald et al. [62, 63] reported a device for 
the reproducible creation of transverse fractures in canine tibiae utilizing a three-point 
bending technique. 
Similarly, to compare the effects of reamed versus unreamed locked intramedullary 
nailing on cortical bone blood flow Schemitsch et al. created a standardized spiral 
fracture by three-point bending with torsion in a fractured sheep tibia model [64, 65], 
a method also described by Tepic [66] to establish a standardized oblique fracture in 
sheep tibiae in order to compare healing in fractures stabilized with either a 
conventional dynamic compression plate (DCP) or an internal point contact fixator 
(PC-Fix). A minimally invasive approach to create a multifragmental fracture in the 
sheep femur (classification by the Association for the Study of Internal Fixation, AO 
type 32-C), in which the bone was weakened by two short, transverse anterior 
osteotomies and bi-cortical drill holes created through small incisions, has recently
been described by Wullschleger et al. (unpublished data, Fig. 3). The insertion of two 
chisels and one blade bar were then used to initiate cracks connecting both the 
osteotomies and the drill holes, thereby creating a standardized multifragmental 
fracture. This technique could easily be adopted when establishing standardized tibial 
fractures as well.
Fracture models of osteotomized long bones have been well characterized over 
the years in different large animal species. A number of publications have described 
fracture models in dogs since the dog, beside pigs, is considered the most closely 
related model for research of human orthopaedic conditions. The effect of bending 
stiffness of external fixators on the early healing of transverse tibial osteotomies was 
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8
described in a canine model by Gilbert [67]. Tiedemann et al. assessed densitometric 
approaches to measure fracture healing in 6-mm tibial segmental defects and single-
cut osteotomy defects in adult mongrel dogs [68]. Bilateral tibial transverse 
osteotomies were performed with a 2-mm gap by Markel et al. to quantify local 
material properties of fracture callus during gap healing [69]. To compare the dosage-
dependent efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2) 
on tibial osteotomy healing, adult female dogs underwent right midshaft tibial 
osteotomies with a 1-mm gap. The operated bones were stabilized using type I 
external fixators [70]. In a similar study by Edwards, bilateral tibial osteotomies were 
performed to evaluate the capacity of a single percutaneous injection of rhBMP-2 
delivered in a rapidly resorbable calcium phosphate paste (alpha-BSM) to accelerate 
bone-healing [71]. The effect of shock wave therapy on acute tibial fractures was 
studied by Wang et al. in adult dogs after creation of bilateral tibial osteotomies with a 
3-mm defined fracture gap [72]. Similar models were also described by Hupel to 
compare the effects of unreamed and reamed nail insertion [73], Jain et al. [74] to 
investigate whether or not the limited contact design of the low-contact dynamic 
compression plate (LC-DCP) provides advantages over the dynamic compression 
plate (DCP) in the context of cortical bone blood flow, biomechanical properties, and 
remodelling of bone in segmental tibial fractures and Nakamura [75] to evaluate 
effects of recombinant human basic fibroblast growth factor (bFGF) on fracture 
healing in beagle dogs.  
As previously mentioned, mature sheep and goats possess a bodyweight 
similar to adult humans, show no major differences in bone mineral composition with 
similar metabolic and bone remodelling rates, and therefore are considered a valuable 
model for human bone turnover and remodelling activity often used in fracture 
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research. In the period between 1990 and 2001, sheep as an animal model were used 
in 9-12% of orthopaedic research, compared to only 5% between 1980 and 1989 [43]. 
Over the last ten years numbers of studies utilizing sheep and goats as animal models 
have even increased to 11-15% [49]. 
The significance of postoperative mechanical stability for bony repair of a 
comminuted fracture was investigated in a sheep study comparing four commonly 
applied operative methods of stabilizing fractures. In this study, a triple-wedge 
osteotomy of the right sheep tibia was used as a fracture model [76]. Using a standard 
osteotomy of the ovine tibia stabilised by an external skeletal fixator, Goodship et al. 
elucidated the influence of fixator frame stiffness on bone healing rates [77]. Wallace 
et al. [78] used a similar model to investigate serum angiogenic factor levels after 
tibial fracture. Likewise, transverse mid-diaphyseal osteotomies with an 
interfragmentary gap of 3 mm, as an experimental fracture model in sheep, were used 
to assess fracture repair processes [79-82]. To validate the principle of external 
fixation dynamization in order to accelerate mineralized callus formation by in vivo
measurements of callus stiffness, transverse fractures with an interfragmentary gap of 
3 mm width were created in the mid third of the tibial diaphysis [83]. Hantes et al. 
investigated the effect of transosseous application of low-intensity ultrasound on 
fracture-healing in a midshaft osteotomy sheep model [84]. Epari et al. were the first 
authors to reported on the pressure, oxygen tension and temperature in the early phase 
of callus tissue formation of six Merino-mix sheep that underwent a tibial osteotomy 
to model fracture conditions [85]. In this study, the tibia was stabilized with a 
standard mono-lateral external fixator. It was found that the maximum pressure during 
gait increased from three to seven days. During the same interval, there was no 
change in the peak ground reaction force or in the interfragmentary movement. 
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Oxygen tension in the haematoma was initially high post-op and decreased steadily 
over the first five days. The temperature increased over the first four days before
reaching a plateau on day four.
Mechanical strain during callus distraction is known to stimulate osteogenesis 
and it is so far unclear whether this stimulus can enhance the healing of a fracture 
without affecting bone length. Just recently, Claes et al., reported for the first time that 
a slow temporary distraction and compression of a diaphyseal osteotomy accelerates 
fracture healing [86] in a mid-diaphyseal osteotomy fracture model of the right tibia in 
sheep, stabilized by external fixation (Fig. 4).
3.2. Tibial segmental defect models 
In order to ascertain whether newly developed bone graft substitutes or tissue 
engineered constructs (TEC) comply with the requirements of biocompatibility, 
mechanical stability and safety, the materials must be subject to rigorous testing both 
in vitro and in vivo. To extrapolate results from in vitro studies to in vivo patient 
situations however is often difficult. Therefore, the application and systematic 
evaluation of new concepts in animal models is often an essential step in the process 
of assessing newly developed bone grafts prior to clinical use in humans. To simulate 
human in vivo conditions as closely as possible, a variety of large critical sized tibial 
defect models - mainly in sheep - have been developed over the past decade in order 
to investigate the influence of different types of bone grafts on bone repair and 
regeneration. Critical sized segmental defects in long bones are usually defined by 
multiplying the shaft diameter by 2.0-2.5 [25, 34]. Interestingly, the method of 
producing the gap may influence the outcome of those studies. Kuttenberger et al. 
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could show that by using a CO2-laser, the osteotomy ends were not as impaired in 
structure as when using an oscillating saw [87].
To evaluate the effects of different bioceramics on bone regeneration during 
repair of segmental bone defects Gao et al. [88] implanted biocoral and tricalcium 
phosphate cylinders (TCP) in sheep tibial defects of 16 mm length. The defects were 
stabilized medially using two overlapping contoured auto-compression plates of 4 mm 
thickness (8 and 6 holes) and cortical screws. When compared to TCP, with the 
biocoral implants, a significant increase in external callus and density was seen after 
three weeks and an increase of torque capacity, maximal angle of deformation and 
energy absorption could be measured after 12 weeks while microscopically 
osseointegration appeared better. However, in his study, Gao used both male and 
female animals with a relatively large variation in body weight. Both factors, gender 
and body weight are known to have an influence on bone regeneration due to effects 
both on the biomechanical environment and hormonal feed-back control mechanisms. 
Hence, variations in sex and body weight should be avoided by all means. The defect 
fixation method used in this study can most likely be interpreted as a means to 
countervail bending forces on the implant after earlier failures. However, defect 
fixation by overlapping plates is not necessarily lege artis and has never been 
introduced and applied clinically to our knowledge. Therefore, a thicker and hence, 
stiffer plate should be chosen instead.
Den Boer et al. reported a new segmental bone defect model where a 30 mm 
segmental defect was inflicted on sheep tibiae and stabilized by an interlocking 
intramedullary nail (custom made AO unreamed humeral nail). X-ray absorptiometry 
was applied to quantify healing [55]. Groups of this pilot study included untreated 
controls and autograft. After 12 weeks, despite higher bone mineral density in the 
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autograft group, no significant difference in torsional strength and stiffness could be 
revealed. Since 33% of the control animals showed sufficient bridging of the defect, it 
needs to be questioned if the authors succeeded in establishing a reliable non-union 
model. Removal of the periosteum or a larger defect site might have been beneficial. 
In a subsequent study, the authors described the fabrication of biosynthetic bone grafts 
and their application in the very same animal model [4]. The five treatment groups 
included empty controls, autografts, hydroxyapatite alone, hydroxyapatite combined 
with rhOP-1, and hydroxyapatite with autologous bone marrow. At 12 weeks, healing 
of the defect was evaluated radiographically, biomechanically and histologically and 
revealed that torsional strength and stiffness were two fold higher for animals treated 
with autograft and hydroxyapatite plus rhOP-1 or bone marrow. Since healing was 
only evaluated after 12 weeks, no conclusions could be drawn regarding the process 
of healing. The mean values of both combination groups were comparable to those of 
autografts. A higher number of defect unions was described when hydroxyapatite plus 
rhOP-1 was applied rather than hydroxyapatite alone. Analysing this study, it has to 
be taken into account that animals treated with hydroxyapatite and bone marrow were 
of a different breed with a higher average body weight. Animals were held at a 
different holding facility and accustomed to unequal forage all of which could 
possibly influence study outcomes.
Bone healing in critical sized segmental diaphyseal defects in sheep tibiae was also 
investigated by Gugala et al. [3, 37]. Defects were bridged with a single porous 
tubular membrane or with anatomically shaped porous double tube-in-tube 
membranes. Membranes with different pore structures were applied alone and/or in 
combination with autologous bone graft. The diaphyseal defects were 40 mm in 
length and stabilized with a bilateral AO external fixator. Operated animals were 6 to 
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7 years of age. Of the six treatment groups however, only in groups where the defect 
was filled with autogenous cancellous bone graft and covered with a single perforated 
membrane or where the bone graft was administered in a space between a perforated 
internal and external membrane, could defect healing be observed. The authors partly 
contribute the healing effect to their membrane system; however a control group, 
where autologous bone graft is administered without any membrane was not 
described. It could also be criticized that post surgery animals were suspended in 
slings over the entire experimental period preventing the animals from sitting and 
therefore getting up, thus not reflecting the normal physiological load bearing 
conditions. 
Wefer et al. [89] conducted a study to develop and test a scoring system based 
on real-time ultrasonography to predict the healing of a bone defect filled with a 
porous hydroxyapatite bone graft substitute or cancellous bone graft from the iliac 
crest and stabilized by anterolateral plate osteosynthesis. After sacrifice tibiae were 
tested in torsion to failure. The results were correlated with radiographic and 
ultrasound scores obtained. Sheep with ceramic implants that developed non-unions 
showed a significantly lower score than sheep with sufficient implant integration. A 
significant correlation between these scores and the biomechanical results was found. 
However, although the authors describe their 20 mm defect as a critical sized model, 
no control group was included for comparison. Hence, based on the clinical 
experience in sheep the contributing authors from three different research groups have 
gathered over the years, and the definition of a critical defect length requiring at least 
2-2.5 times the diameter of the bone, the critical nature of the defect in this study can 
be questioned.
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The effects of new resorbable calcium phosphate particles and paste forms, 
which harden in situ after application, on bone healing were investigated by Bloemers 
et al. [90]. They used a 30 mm segmental tibial defect fixed by a custom made AO 
unreamed interlocking titanium tibial nail. Twelve weeks after defect reconstruction, 
radiological, biomechanical, and histological examinations were performed. 
Radiographically, the resorbable paste group performed better than all other groups. 
Biomechanical tests revealed a significantly higher torsional stiffness for the 
resorbable calcium-phosphate paste group in comparison with autologous bone. The 
study indicated that new calcium phosphate based materials might be a potential 
alternative for autologous bone grafts in humans. As with several other studies 
critically reviewed in this article, animals of a minimum age of 2 years with a 
significant variation in body weight were used in this study. As mentioned before, it 
must be considered that secondery osteonal bone remodelling in sheep does not occur 
until an age of 7-9 years. Therefore, it might be difficult to extrapolate results from 
this study for applications in adult human patients as human bone primarily undergoes 
secondery osteonal bone remodelling. Insulin-like growth factor I (IGF-1) exerts an 
important role during skeletal growth and bone formation. Therefore, its localized 
delivery appears attractive for the treatment of bone defects. To prolong IGF -1 
delivery, Meinel et al. entrapped the protein into biodegradable poly(lactide-co-
glycolide) microspheres and evaluated the potential of this delivery system for new 
bone formation in a non-critical 10 mm segmental tibia defect [91]. The defect was 
stabilized using a 3.5 mm 11 hole DCP. Administration of 100 µg of IGF-1 in the 
microspheres resulted in bridging of the segmental defect within 8 weeks. To avoid 
excessive load on the operated limbs and fracturing of the freshly operated tibial 
defects, the animals were accommodated in a suspension system for a period of 4 
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weeks postoperatively thus preventing physiologic-like biomechanical conditions. 
When interpreting data published in this study, it must be taken into account that the 
close position of the screws to the defect proximally and distally, and the obvious fact 
that the screws at the defect site had not been inserted at a defined angle might have 
influenced and biased the outcomes. 
In a 48 mm tibial defect model in sheep ceramic implants of 100% synthetic calcium 
phosphate multiphase biomaterial were evaluated [92]. The defect was stabilized with 
a 4.5 mm neutralizing plate. Although not reported by the authors, one can observe 
bent plates and axial deviations in presented x-ray and CT images, hence, from a 
clinical point of view, it must be concluded that the chosen fixation in that model 
seemed not to be sufficient (Fig. 5). The x-ray series of the 2 year animal suggests that 
the internal fixation device had been explanted 12-14 weeks post surgery, a fact not 
described and explained by the authors. Assuming recovery and bone regeneration 
without any complications, in human patients, internal fixation devices would usually 
not be removed until 12-18 months post implantation. Good integration between the 
ceramic implants and the adjoining proximal and distal bone ends was observed. A 
progressive increase in new bone formation was seen over time, along with 
progressive resorption of the ceramic scaffold. Based on x-ray analysis, at the one-
year time-point, approximately 10% to 20% of the initial scaffold substance was still 
present, and after two years it was almost completely resorbed. The authors state that 
approximately 10-20% of the periosteum was deliberately left in situ as a source of 
osteogenic cells. However, one might conclude that this procedure appears to be 
rather difficult to standardize in order to develop a reproducible model. 
Another study using an ovine segmental defect model investigated the 
influence of rhTGFβ-3 on mechanical and radiological parameters of a healing bone 
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defect [93]. In 4-5 year old sheep, an 18 mm long osteoperiosteal defect in the tibia 
fixed with a unilateral external fixator was treated by rhTGFβ-3 delivered by a 
poly(L/DL-lactide) carrier, with the carrier only, with autologous cancellous bone 
graft, or remained untreated. Weekly in vivo stiffness measurements and radiological 
assessments were undertaken as well as quantitative computed tomographic 
assessments of bone mineral density in 4 week intervals. The follow up of the 
experiment was 12 weeks under partial weight bearing since animals were kept in a 
support system to prevent critical loads on the fixator and its interface to bone thus not 
reflecting physiological loading conditions. The 18 mm defect size described as 
spontaneously non-healing, might not have been sufficient to establish a non-union 
model in a fully weight bearing biomechanical environment. In the bone graft group, a 
significantly higher increase in stiffness was observed than in the PLA/rhTGFβ-3 
group and a significantly higher increase than in the PLA-only group. The 
radiographic as well as the computer tomographic evaluation yielded significant 
differences between the groups, indicating the bone graft treatment performed better 
than the PLA/rhTGFβ-3 and the PLA-only treatment. 
Sarkar et al. assessed the effect of platelet rich plasma (PRP) on new bone 
formation in a 25 mm diaphyseal tibial defect in sheep [94]. The defect was stabilized 
with a custom-made intramedullary nail (stainless steel, diameter proximal 12 mm, 
distal 10 mm) with two locking screws each proximal and distal. To reduce stress at 
the screw/bone interface, a custom made stainless steel plate was additionally applied 
medially representing an unconventional fixation method not found in the clinic. 
However, no reasoning for the additional medial plating was provided in the 
publication by the authors. Defects were treated with autogenous PRP in a collagen 
carrier or with collagen alone. A control group to establish the critical nature of the 
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defect was not included and has therefore to be questioned. After 12 weeks, the 
explanted bone specimens were quantitatively assessed by X-ray, computed 
tomography (CT), biomechanical testing and histological evaluation. Bone volume, 
mineral density, mechanical rigidity and histology of the newly formed bone in the 
defect did not differ significantly between the PRP treated and the control group, and 
no effect of PRP upon bone formation was observed. 
In 2007 Tyllianakis [95] determined the size of a bone defect that can be 
restored with one-stage lengthening over a reamed intramedullary nail in sheep tibiae. 
Sixteen adult female sheep were divided into four main groups: a simple osteotomy 
group (group I) and three segmental defect groups (10, 20, and 30 mm gaps, groups 
II-IV). One intact left tibia from each group was also used as the non-osteotomized 
intact control group (group V). In all cases, the osteotomy was fixed with an 
interlocked Universal Humeral Nail (UHN-Protek-Synthes). Healing of the 
osteotomies was evaluated after 16 weeks by biomechanical testing. The examined 
parameters were torsional stiffness, shear stress, and angle of torsion at the time of 
fracture. The regenerate bone obvious in x-rays in the groups with 10 and 20 mm gaps 
had considerable mechanical properties. Torsional stiffness in these two groups was 
nearly equal and its value was about 60% of the stiffness of the simple osteotomy 
group. Gradually decreasing stiffness was observed as the osteotomy gap increased. 
No significant differences were found among the angles of torsion at fracture for the 
various osteotomies or the intact bone. These results showed that the group with the
10 cm gap had 65% of the shear stress at failure compared to the simple osteotomy 
group. 
Teixeira et al. treated tibial segmental defects of 35 mm size in both male and 
female sheep aged four to five months. Considering the age of the animals and the 
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preservation of the periosteum, the critical size of this defect can be questioned and 
results cannot necessarily be extrapolated to adult humans, as described correctly by 
the authors. An empty control group was not included in the experiment. The bone 
defects in the diaphysis of the right hind limb were stabilized with a titanium bone 
plate (103 mm in length, 2 mm thickness, and 10 mm width) combined with a 
titanium cage. As reported by the authors, plate bending occurred in 42% of the 
animals and was partly attributed to the connection of the titanium cage to the plate. 
However, it appears that the bending of the plate was rather a result of insufficient 
thickness of the fixation device. The titanium cages were either filled with autologous 
cortical bone graft or with a composite biomaterial consistent of inorganic bovine 
bone, demineralised bovine bone, a pool of bovine bone morphogenetic proteins 
bound to absorbable ultra-thin powdered hydroxyapatite and bone-derived 
denaturized collagen. Bone defect healing was assessed clinically, radiographically 
and histologically. Titanium cages might keep implanted scaffolds and biomaterials in 
place initially and biomechanically support defect fixation, however, it must be taken 
into consideration that – since titanium is not resorbable – the cages might hinder 
complete bone remodelling in the long run. 
Radiographic examination showed initial formation of periosteal callus in both groups 
at osteotomy sites, over the plate or cage 15 days postoperatively. At 60 and 90 days 
callus remodelling occurred. Histological and morphometric analysis 90 days post 
surgery showed that the quantity of implanted materials still present were similar for 
both groups while the quantity of newly formed bone was less (p=0.0048) in the 
cortical bone graft group occupying 51 +/- 3.46% and 62 +/- 6.26% of the cage space, 
respectively [96].
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Recently, Liu et al. reported on the use of highly porous beta-TCP scaffolds to 
repair goat tibial defects [13]. In this study, fifteen goats were randomly assigned to 
one of three groups, and a 26 mm-long defect at the middle part of the right tibia in 
each goat was created and stabilized using a circular external fixator. In Group A, a 
porous beta-TCP ceramic cylinder that had been loaded with osteogenically induced 
autologous bone marrow stromal cells was implanted in the defect of each animal. In 
Group B, the same beta-TCP ceramic cylinder without any cells was placed in the 
defect. In Group C, the defect was left untreated. In Group A, bony union could be 
observed by gross view, X-ray and micro-computed tomography (µCT) detection, and 
histological observation at 32 weeks post-implantation. The implanted beta-TCP 
scaffolds were almost completely replaced by host bone. Bone mineral density in the 
repaired area of Group A was significantly higher than in Group B, in which scant 
new bone was formed in each defect and the beta-TCP hadn't been completely 
resorbed after 32 weeks. Moreover, the tissue-engineered bone of Group A had 
similar biomechanical properties as the contralateral tibia in terms of bending strength 
and Young's modulus. In Group C, little or no new bone was formed and non-union 
occurred, demonstrating the critical nature of the defect. 
To investigate the effect of chondroitine sulphate on bone remodelling and 
regeneration, Schneiders et al. [97] created a 30 mm tibial mid-diaphyseal defect site 
and reconstructed it using hydroxyapatite/collagen cement cylinders. Defect 
stabilization was achieved by insertion of a universal tibial nail (UTN, Synthes, 
Bochum). However, to place the scaffold into the defect, the authors had to use a 
second operative aditus mid-diaphyseally. The published data suggest problems with 
defect fixation not only due to reported implant failures but also to clearly evident 
signs of locking bolt loosening, poor contact between bone and nail, and the proximal 
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nail end extending into the articular space (Fig. 6), facts not reported by the authors. 
Moreover, it can be supposed that either the insertion of the nail or undesired 
movement of the loosened nail has caused damage to the cylindrical biomaterials at 
testing. When interpreting the acquired data, it also has to be taken into account that 
obviously no fabrication method has been described to reliably reproduce implants of 
corresponding geometrical shape. 
The rapid progression of bone graft research and the great number of novel 
developments must be supported by systematic assessment based on clinical 
practicability and experience, the knowledge of basic biological principles, medical 
necessity, and commercial practicality. From our literature review, it can be 
concluded, that in a majority of the mentioned studies, follow up periods, which in 
most cases don’t exceed 6 months, are not suitable to evaluate long term effects of 
bone substitutes and scaffolds on bone regeneration and remodelling, and to 
determine in vivo resorption kinetics of the respective biomaterial. Variations in 
defect sizes and methods of defect fixation as well as postoperative treatment and 
management concepts make it difficult to compare studies and draw reliable 
conclusions. The modifications of commercially available fixation devices and 
supporting systems to prevent peak loads from acting on implants suggest the 
occurrence of implant failures usually expected early after surgery. As a result, most 
experimental settings do not reflect the actual clinical conditions faced and impede the 
extrapolation of results. 
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4. Conclusions and Opinions
The reconstruction of large bone segments remains a significant clinical 
problem. Large bone defects occur mainly as a result of extensive bone loss due to 
pathological events such as trauma, inflammation, and surgical treatment of tumours. 
Present therapeutic approaches include the application of bone graft transplants 
(autologous, allogenic, xenografts), as well as implants made of different synthetic 
and natural biomaterials or segmental bone transport. However, no existing therapy 
has been proven to be fully satisfactory. A large number of research groups 
worldwide work on the development of new bone grafting materials, carriers, growth 
factors, and tissue engineered constructs for bone regeneration and are therefore 
interested to evaluate their concepts in reproducible large segmental defect models. 
The optimization of cell-scaffold combinations and locally or systemically active 
stimuli will remain a complex process characterized by a highly interdependent set of 
variables with a large range of possible variations. Consequently, these developments 
must be nurtured and evaluated by clinical experience, knowledge of basic biological 
principles, medical necessity, and commercial practicality. The area of bone tissue 
engineering which has its main focus on the development of bioactive materials 
depends on the use of animal models to evaluate both experimental and clinical 
hypotheses. To tackle major bone tissue engineering problems, researchers must rely 
on the functional assessment of biological and biomechanical parameters of generated 
constructs. However, to allow comparison between different studies and their 
outcomes, it is essential that animal models, fixation devices, surgical procedures and 
methods of taking measurements are standardized to achieve the accumulation of a 
reliable data pool as a base for further directions to orthopaedic and tissue engineering 
developments.
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Table captions
Table 1: The table lists a selection of publications on segmental bone defect studies in 
sheep tibiae and summarizes animal age, selected defect size, defect fixation, animal 
housing as well as supportive devices. The majority must be considered short term 
studies where no complete bone remodelling can be expected during the experimental 
period. In many cases, authors fail to report important information concerning animal 
age, housing and supportive devices.
Table 2: Summary of advantages and disadvantages of common defect fixation 
methods
Table 3: Comparison of animal models for fracture and segmental bone defect 
research
Table 4: Summary of human and large animal bone properties
Table 5: Factors influencing the quality and quantity of bone healing in long bone 
critical-sized defects (CSD) 
Table 6: Bone biomechanical properties of different animal species and humans
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Figure captions
Fig. 1: The sheep has become a standard model for understanding the mechanical 
conditions that occur after injury and investigating surgical treatments such as 
segmental defect healing. However, limited work has been published on modelling 
this process. Hence, reconstruction of the musculoskeletal model of the sheep lower 
limb across the complete gait cycle was performed. The figure shows mechanical 
loading on mid-shaft level of the tibia (A). The bones are mainly compressed with 
minor shear forces. Compared to humans, the loading in sheep tibias is in pattern 
similar but in magnitude roughly half of the one in humans (B) [52]. 
Fig. 2: Ground and polished sections of MMA embedded sheep tibia stained with 
Toluidine blue. a) Plexiform/laminar appearance of cortical bone with longitudinally 
arranged vessels (arrows) between the bone lamellae. Absence of a clearly visible 
cement line between adjacent lamellae. Scale bar = 200μm. b) Remodelling of an area 
with originally plexiform bone which has been replaced by secondary osteons (*). 
Scale bar = 50μm. c) Remodelling of plexiform bone in the immediate neighbourhood 
of an implant. During healing and subsequent remodelling new bone is deposited in 
form of secondary osteons, seen in the upper part of the image (*). Scale bar = 50μm. 
d) Transversely cut secondary bone with numerous osteons that can be clearly 
distinguished. The cement lines that separate neighbouring osteons (arrows). Scale bar 
= 50μm.
Fig. 3: Ovine femoral multifragmentory fracture (AO type 32-C) right after (A) and 8 
weeks post surgery (B).
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Fig. 4: Histological pictures of the fracture callus (Paragon stain) of right tibiae, 8 
weeks after surgery. Left side: temporary distraction animal with larger callus and 
bridging of the osteotomy gap at one site by calcified bone. The connective tissue has 
a light blue color. Right side: control animal with smaller callus (red) and remaining 
interfragmentary zone of fibrocartilage (violet).
Fig. 5: Implant bending 1.5 months after surgery (A) and tibial axial deviation 7.5 
months post treatment (B).
Fig. 6: 3 cm tibial mid-diaphyseal defect site reconstructed with 
hydroxyapatite/collagen cement cylinders.  Signs of locking bolt loosening (arrow) 
and the proximal nail end extending into the articular space are evident 12 weeks after 
implantation.
Fig. 7: Schematic representation of commonly applied methods for the fixation of 
segmental defects in large animal models. A) Plate fixation, B) External fixator, C) 
Intramedullary nail.
Fig. 8: 2-cm segmental bone defect in a sheep tibia stabilized with a narrow 4.5 mm 
LC-LCP plate (A); implant failure occurring 2 days post surgery (B).
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Table 1:
Author Animal 
age 
(years)
Defect 
size (mm)
Follow-up 
(months)
Fixation Animal 
housing
Support
Gao et al., 1997 a 16 4
Overlapping 
autocompresson 
plates, 8 and 6 
holes, 4 mm 
thickness
a a
DenBoer et al., 1999/03 a 30 3
Custom-made 
AO unreamed 
nail (Synthes)
a a
Gugala et al. 1999/02 6-7 40 4
AO bilateral 
external fixator
Single 
boxes
Suspending 
slings
Wefer et al., 2000 ≥ 2 20 12
Anteerolat. plate 
osteosynthesis 
(not specified)
a a
Bloemers et al., 2003 ≥ 2 30 3
AO unreamed 
tibial nail 
(Synthes)
6-8 animals 
in a 60 m2
cage
a
Meinel et al., 2003 a 10 5 3.5 mmm DCP, 
11 holes
a a
Mastrogiacomo et al, 
2006
2 48 12
4.5 mm plate 
(not specified), 
10-12 holes
Single 
boxes
Fibre glass 
cast
Maissen et al., 2006 4-5 18 3
Unilateral 
external fixator
Single 
boxes
Custom-made 
support 
system
Sarkar et al., 2006 5.5-7 25 3
Custom-made 
intramedullary 
nail plus medial 
stainless steel 
plate
Single 
boxes
a
Tyllianakis et al., 2007 1-2 10,20,30 4
Universal 
Humeral Nail 
(UHN, Synthes)
Single 
boxes for 3 
days post 
surgery
a
Liu et al., 2007 a 26 8 Circular external fixator
Single 
boxes a
ainformation not provided by the authors
Table
1Table 2:
Advantages Disadvantages
External fixator - Versatility
- Ease of application
- Marginal effect on 
surrounding soft tissue
- Minimal intraoperative 
trauma
- Open space for 
implantation of biomedical 
construct
- Clinically only applied as 
temporary fixation device
- Schantz screw loosening
- Pin track infections
Intramedullary nail - Standard treatment for 
diaphyseal fractures of 
lower extremity
- Availability of UTN to 
avoid reaming related 
problems
- Central load carrier
- High tolerance of 
maximum applied forces
- Low axial deviations
- Reaming debris as 
possible source of 
multipotent stem cells
- Impairment of bone blood 
circulation by reaming 
- Thermal necrosis after 
reaming
- Air or fat embolism
- Failure of locking bolts
- Limited application of load-
bearing scaffolds
- Prolonged healing period
Plate fixation - Standard treatment for 
metaphyseal fractures
- Optimal reduction
- Minimal influence on 
defect (LC-LCP)
- Open space for 
implantation of biomedical 
construct
- Eccentrical load carrier
- Impairment of periosteal 
blood flow (non LCP)
- Bone loss through stress 
protection (non LCP)
- Unclear role of plate 
fixation in tibial shaft 
fractures
- Prone to axial deviations 
and implant failure
Table
a Most commonly used 
b Methods to mimic accidental fractures more closely
c In radial, ulnar or fibular fractures where additional bony support is present
Animal species and defect location Defect formation Defect fixation Application
Animal Models of Fracture 
(Osteotomy)
Doga
o Femur [1] [2]
o Tibia [3] [4] [5] [6] [7] [8] [9] [10]
o Radius [11] [12] [13] [14]
Sheepa
o Tibia  [15] [16] [17]  [18, 19] [20] [21]
[22] [23] [24]
Goat
o Tibia [25] [26] [27]
Pig
o Pelvis [28]
o Femur [29]
o Tibia [30] [31]
o Spine [32] [33]
o Manually created 
fracturesb
o Three-point bendingb
o Guillotine-like 
apparatusb
o Oscillating saw, high 
speed dental burr, or 
scissorsb
o Ballistic injury
Internal
o Intramedullary rod/pin
o Plate and screws
o Screws
o Cerclage wires
External
o External fixators
o Casts
o Splints
No fixation
Mice and ratsc
o Study of normal fracture healing
o Drug delivery to fracture sites
o Effects of
      - Drugs
      - Growth hormones
      - Angiogenic factors
      - LASER
            on fracture healing
o Effect of fixation methods on periosteal, cortical and soft 
tissue blood flow [34]
o Effect of type and rigidity of fixation on fracture healing 
and rate of remodelling [35]
o Creation of non-unions [36]
o Creation of an infected ballistic wound model
o Evaluation of various assessments (e.g. x-ray) of 
fracture healing
o In vitro testing of spinal fracture fixation systems
         
Animal Models of Segmental Bone 
Defect (Ostectomy)
Dog 
o Calvaria [37] [38] [39]
o Mandible  [40] [41] [42]
o Radius [43]
o Ulna [44]
o Femur [45] [2] [46]
o Tibia [5]
o Fibula [47], 
Sheep 
o Calvaria [48]
o Mandible [49] [50]
o Femur [51] [52] [53]
o Tibia  [54, 55] [56] [57, 58] [55] [59]
[60]
o Metatarsus [61] [62] [63] [64]
Goat 
o Calvaria [65]
o Mandible [66]
o Iliac wing [67]
o Femur [68] [69] [70]
o Tibia [71] [72]
o Radius [73]
Pig 
o Calvaria [74]
o Tibia [75] [76] [76]
o Fibula [77]
o Radius  [78]
o Spine  [79]
o Oscillating saw
o Gigli’s wire
Internal
o Intramedullary nail/pin
o Plate and screws
External
o External fixators
o Study of integration, degradation and remodelling of 
bone substitutes
 Bone grafting
 Autograft
 Allograft
 Xenograft
 Biomaterials of natural and synthetic origin 
 Demineralised bone matrix
 Biomaterials [80]
1. Hydroxyapatite/tricalcium-phosphate 
ceramics
2. Polymers
3. Metals
4. Composites 
o Bone substitutes plus autogenous bone marrow
o Evaluation of osteogenic potential of cell-seeded 
composite implants
o Assessment of osteoinductive properties of growth 
factors
Table 3:
Table
a Number of Haversian systems per square millimetre 
b Average whole body trabecular bone turn over per year
Micro-structure
[81] [82] [83, 84]
Macro-structure
[85] [86] [87]
Application
[88]
Disadvantages
[81] [89] [84] [88]
Advantages
[88] [90] [89]
Bone 
remodellingb 
[88]
Bone 
composition 
[88]
Diameter (μ) of
Haversian 
system 
[83]
Haversian 
canal
[83]
Dog
o Woven-fibered bone (plexiform 
bone)
o Secondary osteons (with small 
canals) increase in number with 
age
Femur:
Pronounced curvature at distal 
third of shaft; narrow in the middle
Tibia:
Length Similar to sheep; proximally 
convex medially, distally convex 
laterally; proximal ⅓ prismatic, 
remainder cylindrical
Musculoskeletal and 
dental research
o Higher rate of
solid bony fusion 
when compared to 
humans
o Low non-union 
rates
o Ethical issues 
and negative public 
perception
o Significant inter-
animal variations 
due to breed 
diversity
o Tractable 
nature
o Similar bone 
mineral density to 
humans
100%
Bone mineral 
density similar 
to humans
125-175 15-50
Sheep
Primary bone structure (plexiform 
cortical bone) in young sheep (3-4 
years of age)
Femur:
Rounded (cylindrical) shaft; convex 
dorsally; curved in distal ⅔; regular 
in diameter
Tibia:
Major weight-bearing bone of crus; 
long and slender; shaft curved 
medially and caudally at centre; 
round in middle, triangular 
proximally, flattened cranio-
caudally in distal third; medial 
surface is subcutaneous
Orthopaedic research
o Age-dependant 
bone remodelling
o Haversian 
remodelling at 7-9 
years of age (with 
medium-sized, 
irregular canals)
o Docile animals
o Similar body weight 
to humans
o Dimension of long 
bones suitable for 
human implants
Larger amount 
of bone in-
growth than 
humans
Higher 
trabecular bone 
density than 
humans
(0.61g/cm3)
75-360 18-120
Goat
Non-homogeneously distributed 
Haversian systems
Almost identical to sheep Research on 
cartilage, menisci 
and ligamentous 
repair
Inquisitive and 
interactive nature
More tolerant to ambient 
conditions
Similar to 
humans
Very similar to 
human
50-325 18-70
Pig
o Plexiform bone (osteonal 
banding)
o Dense Haversian bone (with 
medium canals), increases with 
age
Femur:
Relatively wide & massive 
diaphysis with 4 surfaces
Tibia:
Slightly curved diaphysis, convex 
medially
Orthopaedic and 
dental studies 
(femoral head 
osteonecrosis, 
fractures, bone in-
growth, dental 
implants)
o High growth rates 
and excessive body 
weight
o Difficult handling
Bone mineral density, 
anatomy, morphology, and 
healing similar to humans
Similar to 
humans
Bone mineral 
density similar 
to humans
Human
o Mainly circumferential lamellar 
bone
o Woven-fibered bone (plexiform) 
formed only in rapid bone repair 
and remodelling
o More Haversian bone than 
quadrupeds (12.87 vs. 5.5a)
o Epiphysis- proximal 
and distal-spongy bone
o Metaphysis- transition zone-
spongy bone distal to 
epiphyseal line
o Diaphysis - shaft of the bone –
compact bone 
10-15% to 40-
55%
Trabecular 
bone density:  
0.43 g/cm3
180-325 27-170
Table 4:
Table
Table 5:
Factors determining a CSD [1] [2, 3]
o Age
o Species phylogeny 
o Defect size
o Anatomic location
o Bone structure and vascularisation
o Presence of periosteum 
o Adjacent soft tissue
o Mechanical loads and stresses on the limb 
o Metabolic and systemic conditions
o Fixation method/stiffness 
o Nutrition
Table
1Table 6:
Bone biomechanical properties
Cortical bone Trabecular bone
Dog
Humerus (bending)
E: 2.66 (GPA)
UStress 193.23 (MPa) [93]
Femur
E: 209 (MPa)
Ustress: 7.1 (MPa)
Tibia
E: 106-426 (MPa)
Ustress: 2-24 (MPa)
[81]
Sheep
Femur (compression)
E:19.3 (GPa)
UStrain: 0.019 [94] [95]
Tibia
E: 1192  (MPa) Ustress: 21.4 (MPa)
[96]
Goat
Tibia (bending)
E: 278.08 (MPa)
Bending strength: 46.24 (MPa) [71]
Femur
E: 399-429 (MPa)
Ustress: 14.1-23.5 (MPa)
Tibia
E: 532-566 (MPa)
Ustress: 24.7-26.1 (MPa)
Pig
Femur
E: 14.6 (GPa) (plexiform bone)
8.3 (GPa) (Haversian bone) [97]
Femur
E: 5900 (MPa)
[81]
Human
Femur (compression)
E: 14.7-19.7 (GPa)
UStrain: 167-215 (MPa)
Tibia (compression)
E: 24.5-34.3 (GPa)
UStrain: 183-213 (MPa) [81]
Femur
E: 298 (MPa) UStrain: 5.6 (MPa)
Tibia
E: 445 (MPa)
UStrain: 5.3 (MPa) [81]
Table
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Supplementary information
Intramedullary nailing
Intramedullary nailing was first introduced by Küntscher in 1953 [1] and once 
established, reaming soon advanced as a novel endorsement [2]. With the 
enhancement of intramedullary fixation devices and development of locked nailing, 
the indications for intramedullary stabilisation have been further expanded over the 
years making it a popular option in long bone fracture management. The treatment of 
diaphyseal fractures of the lower extremity has advanced as a commonly accepted 
standard treatment [3, 4]. Despite its wide-spread application, intramedullary nailing 
is associated with both positive and negative side aspects. It has been reported that the 
process of reaming leads to a considerable impairment of bone blood circulation by 
largely destroying both the intramedullary arterial and venous system [5,6]. The 
reaming procedure as well as the insertion of the nail causes a significant increase of 
intramedullary pressure. This increase in pressure can lead to both air or fat 
embolisms by intravasation of bone marrow or fat into the vascular system and the 
formation of microthrombi causing pulmonary microvascular damage [7, 8]. The 
process of reaming may also lead to a rise in temperature in the medullary canal. 
Rises in temperature of 50°C and more have been described [9, 10]. As a result, 
thermal necrosis of bone tissue with alteration of endosteal architecture and biological 
failure may be induced compromising fracture or defect healing [11]. In most cases 
however, the damage of local tissue is reversible and compensated for within 6-8 
weeks. Weak spot of various unreamed nailing systems prone to failure pose the 
interlocking screws and small dimension solid tibial nails do not always provide 
adequate stability in the proximal and/or distal defect site. The rate of failure however 
*Manuscript
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could be reduced over the years with advances in surgical techniques, optimization of 
materials and with the use of e.g. angle stable locking bolts [12], and postoperative 
treatment concepts. When discussing intramedullary stabilization in the context of 
tissue engineering and the evaluation of biomaterials and constructs for bone graft 
substitution, it must be considered, that, in a created defect area, an intramedullary 
nail impedes the placement of a solid, one-piece load-bearing scaffold (Fig. 7). 
However, since central load carriers are less susceptible for tilting in the frontal plane, 
custom made intramedullary nailing systems have been widely applied for fixation of 
large segmental bone defects in animal models [13-16]. 
Reaming mobilizes cancellous bone within the medullary canal which is likely to 
assemble in the area of the fracture gap. The effects of the collected material at the 
gap are comparable to conventional bone graft from the iliac crest suggesting that 
reaming debris represents a possible source of multipotent stem cells and growth 
factors enhancing regeneration processes [17-19].
Internal plate fixation
While intramedullary stabilisation is the treatment of choice when reconstructing 
closed diaphyseal shaft fractures, metaphyseal fractures are usually stabilised by 
extramedullary implants, preferably angle-stable plates, pre-shaped in an anatomical 
fashion where applicable [4]. Optimal reduction and good stability even in 
complicated fractures can be achieved by plate and screw osteosynthesis [20, 21]. 
After conventional plate osteosynthesis however, in most cases histologically and 
radiologically verifiable bone loss can be detected (principal of friction). This 
phenomenon has been attributed to stress protection according to Wolff’s law. 
Clinical observations and recent studies however have revealed the occurrence of 
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certain porosity within the cortical bone proximate to the plate during the early phase 
following plate osteosynthesis. This porosity was found to be a result of impaired 
perfusion underneath the plate [22]. The decrease in perfusion in proximity to the 
plate results from high compression forces between plate on the one hand and 
periosteum and bone on the other [23]. The contact pressure and the resulting 
circulatory disturbance prolongate fracture healing and increase the risk of infection 
and refracture after implant removal [24]. To overcome these drawbacks, a plate 
system was developed where load and torque transmission can act through the screws 
only. This was achieved by angle-stable, interlocking screws. As a result, to achieve a 
stable fracture fixation, the plate-bone contact was not further necessary as the 
stabilisation system acted rather like an internal fixator. The application of 
monocortical screws can further minimize screw-related intramedullary circulatory 
disturbances [25]. The development of such new biological techniques and implants 
has revived the interest towards open reduction and plate fixation. Nevertheless, the 
exact role of plate fixation in the treatment of tibial shaft fractures remains unclear, as 
the literature is lacking randomised control trials comparing plate fixation with the 
other established treatment concepts. In the area of tissue engineering and related 
animal experiments, defect fixation with internal fixators offers the great advantage of 
a minimal influence of the fixation device on the created defect site both concerning 
space for scaffold implantation and biological factors. When compared to external 
fixators or tibial nails, rates of infections (pin-track infection), infection related 
complications and non-union rates (6-25%) are lower. However, higher numbers of 
malalignment can be observed [26]. Especially in large animal models, defect fixation 
with eccentrically placed devices seems to be challenging and was used only in few 
studies [27-29] (Fig. 8). Since in most reports, complications, implant failures, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
postoperative treatment and animal care are not published and authors have described 
unconventional methods of defect fixation such as the use of overlapping plates [30] 
and the use of other supportive devices it can be assumed that implant modifications 
and the use of supportive devices were a necessary protective measure to overcome 
implant failures early after surgery resulting from critical loads/valgus stress 
occurring during the act of the animal uprising with the relatively long tibia serving as 
the lever arm of the force. 
External fixator
In clinical settings, external fixation is often used as a temporary fixation 
device in patients with severe open or contaminated fractures or in the case of 
multiple traumas. Switch from external to internal fixation is best done as soon as the 
soft tissue problems are resolved [31, 32]. In animal models, external fixators have 
been widely used as they offer versatility and ease of application [33-35]. External 
fixators affect the surrounding soft tissue only marginally due to minimal 
intraoperative trauma. The most common complication when using external fixation 
systems is loosening of Schanz screws and following pin track infections. When 
compared to intramedullary nails, external fixators don’t affect the defect site as 
extensively not limiting space for the implantation of biomedical, tissue engineered 
constructs. However, with external fixators healing periods are reported to be 
significantly longer when compared to other fixation devices [36]. Moreover, external 
fixators may be a burden for the animals as they represent an obstacle larger than the 
physiological circumference of the animal limb.
Mueller et al reported on a study designed to identify what levels of primary stability 
could be achieved with different forms of osteosynthesis in the treatment of 
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diaphyseal fractures of the tibia. Treatment concepts included unreamed tibial nails 
(UTN), cannulated tibial nails (CTN), lateral tibial head buttress plates (LPO, 
Synthes), and 5-hole proximal lateral tibia less invasive stabilising systems (LISS), 
external fixators and hybrid fixators (Synthes) [37]. It was shown that the nailing 
systems as central load carriers tolerate higher maximum applied forces. The lowest 
axial deviations in varus and valgus direction were again described for the 
intramedullary nailing devices while the highest axial deviations were recorded for 
the plate fixations.  
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